ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 3055

Ultrasound Features of the First Metatarsophalangeal Joint in Gout and Asymptomatic Hyperuricaemia: Comparison with Normouricaemic Individuals

Sarah Stewart1, Nicola Dalbeth2,3, Alain Vandal4, Bruce Allen5, Rhian Miranda6 and Keith Rome7, 1School of Podiatry, Auckland University of Technology, Auckland, New Zealand, 2Auckland District Health Board, Auckland, New Zealand, 3Department of Medicine, University of Auckland, Auckland, New Zealand, 4Counties Manukau District Health Board, Auckland, New Zealand, 5Horizon Radiology, Auckland, New Zealand, 6Auckland City Hospital Radiology, Auckland, New Zealand, 7School of Clinical Sceince, Health & Rehabilitation Research Institute, AUT University, Auckland, New Zealand

Meeting: ACR/ARHP Annual Meeting 2016

Date of first publication: September 28, 2016

Keywords: foot, gout and ultrasound

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: ACR/ARHP Combined Abstract Session: Orthopedics and Rehabilitation

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: The first metatarsophalangeal joint (1MTPJ) is frequently affected in gout. This study aimed to identity ultrasound features of the 1MTPJ in people with gout and people with asymptomatic hyperuricaemia compared with normouricaemic controls.

Methods: Participants with gout (n=23), asymptomatic hyperuricaemia (n=29) and age- and sex-matched normouricaemic control participants (n=34) underwent a grey-scale and power Doppler ultrasound assessment of both 1MTPJs using a Phillips iU22 ultrasound machine with a 10 MHz, 55mm linear array transducer. No participants had clinical evidence of gout flare at the time of scanning. The images were assessed by two blinded independent radiologists for the presence of the double contour sign, tophus, erosion, effusion, synovial hypertrophy, and synovitis. Cartilage thickness and tophus diameter were also measured. Inter-reader reliability was assessed using Cohen’s kappa (ƙ) and intra-class correlation coefficients (ICC). Binary logistic and linear regression models were used to determine between-group differences in the ultrasound features. A stepwise linear regression was used to determine which ultrasound features were independently associated with gout compared with asymptomatic hyperuricaemia.

Results: Inter-reader reliability was moderate for the presence of the double contour sign, tophus, erosion, synovial hypertrophy and effusion (ƙ=0.42 to 0.59), good for synovitis (ƙ=0.66) and excellent for cartilage thickness and tophus diameter (ICC=0.81 and 0.86 respectively). Compared to normouricaemic control participants, participants with gout and with asymptomatic hyperuricaemia had more frequent double contour sign (Table, odds ratio (OR) 3.91, P=0.011 and OR 3.81, P=0.009, respectively). Participants with gout also had more erosion (OR 10.13, P=0.001) and synovitis (OR 9.00, P<0.001) and had greater tophus diameter (0.00mm vs. 1.68mm, P=0.035). There was no significant difference in cartilage thickness between groups. More severe erosion and synovitis grades and a less severe effusion grade were independently associated with a diagnosis of gout compared with asymptomatic hyperuricaemia (R2 for model = 0.65, p < 0.001).

Conclusion: Urate deposition, synovitis and bone erosion are common at the 1MTPJ in people with gout, even in the absence of flare. Furthermore, although individuals with asymptomatic hyperuricemia lack ultrasound features of inflammation or structural joint changes, they demonstrate a similar frequency of urate deposition. These data support the concept that gout is a disease of chronic inflammation in response to intra-articular urate crystal deposition.

Table. Odds ratios for the presence of ultrasound features at the 1MTPJ

Present,    n (%)

Odds Ratio†

95% CI for OR

p

Lower

Upper

Double Contour Sign

Control

9 (13%)

Gout

17 (37%)

3.91

1.37

11.20

0.011

AH

21 (36%)

3.81

1.41

10.36

0.009

Tophus

Control

0 (0%)

Gout

6 (13%)

5.08

0.96

27.08

0.057

AH

0 (0%)

1.00

0.12

8.26

1.000

Erosion

Control

2 (3%)

Gout

15 (33%)

10.13

2.75

37.28

0.001

AH

1 (2%)

0.83

0.14

4.88

0.83

Effusion

Control

12 (18%)

Gout

4 (9%)

0.45

0.13

1.61

0.22

AH

13 (22%)

1.34

0.51

3.54

0.55

Synovial hypertrophy

Control

0 (0%)

Gout

1 (2%)

3.25

0.67

15.73

0.14

AH

2 (3%)

1.72

0.32

9.13

0.52

Synovitis

Control

5 (7%)

Gout

20 (44%)

9.00

3.10

26.08

<0.001

AH

2 (3%)

0.60

0.14

2.69

0.51

†Reference category: control group; AH = Asymptomatic hyperuricaemia


Disclosure: S. Stewart, None; N. Dalbeth, None; A. Vandal, None; B. Allen, None; R. Miranda, None; K. Rome, None.

To cite this abstract in AMA style:

Stewart S, Dalbeth N, Vandal A, Allen B, Miranda R, Rome K. Ultrasound Features of the First Metatarsophalangeal Joint in Gout and Asymptomatic Hyperuricaemia: Comparison with Normouricaemic Individuals [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/ultrasound-features-of-the-first-metatarsophalangeal-joint-in-gout-and-asymptomatic-hyperuricaemia-comparison-with-normouricaemic-individuals/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2016

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-features-of-the-first-metatarsophalangeal-joint-in-gout-and-asymptomatic-hyperuricaemia-comparison-with-normouricaemic-individuals/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology